Eli Lilly
LLY
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
InvestorPlace • 1 day ago • LLY
Pharma Stocks Outlook: Where Are 2024's Top Performers Headed Next?InvestorPlace • 1 day ago • LLY
Rally Rockets: 3 Stocks Benefitting From the Market's Unstoppable SurgeZacks Investment Research • 2 days ago • LLY
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C ControlZacks Investment Research • 2 days ago • LLY
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 2 days ago • LLY
3 Stocks to Buy Following Positive Earnings ResultsCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.